These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10835998)

  • 21. Pain management in children and adolescents with sickle cell disease.
    Jerrell JM; Tripathi A; Stallworth JR
    Am J Hematol; 2011 Jan; 86(1):82-4. PubMed ID: 20949441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of analgesic use in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    Clin J Pain; 2007 Jan; 23(1):8-14. PubMed ID: 17277639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The management of pain in sickle cell disease.
    Shapiro BS
    Pediatr Clin North Am; 1989 Aug; 36(4):1029-45. PubMed ID: 2666928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexmedetomidine as an Adjuvant to Analgesic Strategy During Vaso-Occlusive Episodes in Adolescents with Sickle-Cell Disease.
    Sheehy KA; Finkel JC; Darbari DS; Guerrera MF; Quezado ZM
    Pain Pract; 2015 Nov; 15(8):E90-7. PubMed ID: 26205912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current issues in sickle cell pain and its management.
    Ballas SK
    Hematology Am Soc Hematol Educ Program; 2007; ():97-105. PubMed ID: 18024616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychosocial and pharmacological management of pain in pediatric sickle cell disease.
    Hildenbrand AK; Nicholls EG; Daly BP; Marsac ML; Tarazi R; Deepti R
    Postgrad Med; 2014 Mar; 126(2):123-33. PubMed ID: 24685976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WITHDRAWN: Pain management for sickle cell disease in children and adults.
    Dunlop R; Bennett KC
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD003350. PubMed ID: 24711059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pain experience of children with sickle cell disease who had prolonged hospitalizations for acute painful episodes.
    Jacob E; Mueller BU
    Pain Med; 2008; 9(1):13-21. PubMed ID: 18254762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis.
    Yaster M; Tobin JR; Billett C; Casella JF; Dover G
    Pediatrics; 1994 Feb; 93(2):310-5. PubMed ID: 8121746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional anesthesia for sickle cell disease vaso-occlusive crisis: A single-center case series.
    Karsenty C; Tubman VN; Liu CJ; Fasipe T; Wyatt KEK
    Pediatr Blood Cancer; 2022 Jun; 69(6):e29695. PubMed ID: 35373913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The management of painful crisis in sickle cell disease.
    Wright J; Ahmedzai SH
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):97-106. PubMed ID: 20440206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID; Woodward M; Reed GW
    Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sickle cell vaso-occlusive pain crisis in adults: alternative strategies for management in the emergency department.
    Sanders DY; Severance HW; Pollack CV
    South Med J; 1992 Aug; 85(8):808-11. PubMed ID: 1302470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature.
    Uprety D; Baber A; Foy M
    Ann Hematol; 2014 May; 93(5):769-71. PubMed ID: 24232306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease.
    Nobrega R; Sheehy KA; Lippold C; Rice AL; Finkel JC; Quezado ZMN
    Pediatr Res; 2018 Feb; 83(2):445-454. PubMed ID: 28902183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pain in sickle cell disease: current and potential translational therapies.
    Sagi V; Mittal A; Tran H; Gupta K
    Transl Res; 2021 Aug; 234():141-158. PubMed ID: 33711512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic opioid use in patients with sickle cell disease.
    Mo G; Jang T; Stewart C; Khoury L; Ferguson N; Egini O; Muthu J; Dutta D; Salifu M; Lim SH
    Hematology; 2021 Dec; 26(1):415-416. PubMed ID: 34102090
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of acute pediatric pain.
    Kraemer FW
    Semin Pediatr Neurol; 2010 Dec; 17(4):268-74. PubMed ID: 21183134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void.
    Solomon LR
    Blood; 2008 Feb; 111(3):997-1003. PubMed ID: 17940207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pain management in sickle cell disease].
    Rasche T; Emmert D; Seidel H; Sellin J; Conrad R; Mücke M
    Schmerz; 2020 Jun; 34(3):285-296. PubMed ID: 32367470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.